These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19187640)

  • 1. The utilization status of aspirin for the secondary prevention of ischemic stroke.
    Ke XJ; Yu YF; Guo ZL; Xu K; Hai H; Zhang AH; Jiang H; Peng H
    Chin Med J (Engl); 2009 Jan; 122(2):165-8. PubMed ID: 19187640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A survey on cerebral infarction/transient ischemic attack inpatients compliance with secondary stroke prevention and follow-up 90 days].
    Ma RH; Wang YJ; Wang CX; Zhao XQ; Wang YL; Xu MJ; Wei M; Li Y; Zhang Z; Zhang WW; Wang L; Lin L; Li HT; Zheng T; Wang XW; Li JJ; Lü Y; Qi D
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2618-22. PubMed ID: 19080709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin non-responders in Thai ischemic stroke/TIA patients.
    Dharmasaroja P
    J Med Assoc Thai; 2008 Jun; 91(6):818-21. PubMed ID: 18697379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin "failures," clopidogrel added to aspirin, and secondary stroke prevention in veterans presenting with TIA or mild-to-moderate ischemic stroke.
    Levine RL; Dixit SN; Dulli DA; Khasru MA
    J Stroke Cerebrovasc Dis; 2003 Jan; 12(1):37-43. PubMed ID: 17903902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex difference in the antiplatelet effect of aspirin in patients with stroke.
    Cavallari LH; Helgason CM; Brace LD; Viana MA; Nutescu EA
    Ann Pharmacother; 2006 May; 40(5):812-7. PubMed ID: 16608908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prescribing patterns of antithrombotic agents for prevention of recurrent ischemic stroke.
    Po HL; Lin YJ; Hseuh IH
    Acta Neurol Taiwan; 2009 Jun; 18(2):98-103. PubMed ID: 19673361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipyridamole-associated headache in stroke patients--interindividual differences?
    Lökk J
    Eur Neurol; 2009; 62(2):109-13. PubMed ID: 19521087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici M; Mattle HP; Rothwell PM;
    Cerebrovasc Dis; 2009; 27(6):608-13. PubMed ID: 19407444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients.
    Georgiadis D; Arnold M; von Buedingen HC; Valko P; Sarikaya H; Rousson V; Mattle HP; Bousser MG; Baumgartner RW
    Neurology; 2009 May; 72(21):1810-5. PubMed ID: 19321846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
    Weber R; Weimar C; Diener HC
    Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discharge medications among ischemic stroke survivors.
    Sweileh WM; Sawalha AF; Zyoud SH; Al-Jabi SW; Abaas MA
    J Stroke Cerebrovasc Dis; 2009; 18(2):97-102. PubMed ID: 19251184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to aspirin in secondary prevention of ischemic stroke.
    Lago A; Tembl JI; Pareja A; Ponz A; Ferrer JM; Vallés J; Santos MT;
    Cerebrovasc Dis; 2006; 21(5-6):353-6. PubMed ID: 16490946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke.
    Alvarez-Sabín J; Penalba A; Quintana M; Krupinski J; García-Bonilla L; Montaner J
    Cerebrovasc Dis; 2009; 28(4):371-7. PubMed ID: 19641312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic interventions for prevention of recurrent ischemic stroke.
    Kirshner HS
    Am J Manag Care; 2008 Jun; 14(6 Suppl 2):S212-26. PubMed ID: 18611103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin resistance determined with PFA-100 does not predict new thrombotic events in patients with stable ischemic cerebrovascular disease.
    Boncoraglio GB; Bodini A; Brambilla C; Corsini E; Carriero MR; Parati EA
    Clin Neurol Neurosurg; 2009 Apr; 111(3):270-3. PubMed ID: 19084329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin nonresponse in patients with arterial causes of ischemic stroke: considerations in detection and management.
    Biller J
    J Neurol Sci; 2008 Sep; 272(1-2):1-7. PubMed ID: 18534625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.